Lee Pharmaceuticals, Inc. filed its 1-A on Sep 13, 2022 for the period ending Dec 31, 2021. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | 0.00% | +100.00% | -96.12% |
1st Jan change | Capi. | |
---|---|---|
-96.12% | 613K | |
+29.94% | 285B | |
+9.29% | 75.95B | |
+2.15% | 68.91B | |
+19.78% | 53.72B | |
+25.70% | 51.56B | |
+1.44% | 47.87B | |
+22.90% | 45.96B | |
+20.39% | 38.39B | |
+26.30% | 29.24B |
- Stock Market
- Equities
- RONN Stock
- News RONN Inc.
- Lee Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt